← Back to Search

Anti-psychotic

Extended-Release Olanzapine for Schizophrenia

Phase 1
Recruiting
Research Sponsored by Teva Branded Pharmaceutical Products R&D, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial aims to understand how the body processes three different forms of olanzapine and to assess their safety and tolerability. It also seeks to evaluate how ZYPREXA is processed in the body

Who is the study for?
This trial is for adults with schizophrenia or schizoaffective disorder, confirmed by DSM-5 criteria. Participants must maintain their smoking status, weigh over 50 kg with a BMI of 18.5 to 38.0, and agree to inpatient stays. Women must test negative for pregnancy or be sterile/postmenopausal; men must be sterile or use birth control.
What is being tested?
The study aims to understand how the body processes three different olanzapine formulations used for treating schizophrenia/psychosis. It also assesses the safety and tolerability of these medications over a period of 19 weeks.
What are the potential side effects?
While not specified here, common side effects of olanzapine can include weight gain, drowsiness, increased appetite, restlessness, dry mouth, and constipation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Experimental Treatment
Group I: Olanzapine Group CExperimental Treatment2 Interventions
Single-dose injection
Group II: Olanzapine Group BExperimental Treatment2 Interventions
Single-dose injection
Group III: Olanzapine Group AExperimental Treatment2 Interventions
Single-dose injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Olanzapine
2005
Completed Phase 4
~5480

Find a Location

Who is running the clinical trial?

Teva Branded Pharmaceutical Products R&D, Inc.Lead Sponsor
253 Previous Clinical Trials
3,485,723 Total Patients Enrolled
5 Trials studying Schizophrenia
1,672 Patients Enrolled for Schizophrenia
Teva Medical Expert, MDStudy DirectorTeva Branded Pharmaceutical Products R&D, Inc.
94 Previous Clinical Trials
38,926 Total Patients Enrolled
5 Trials studying Schizophrenia
1,672 Patients Enrolled for Schizophrenia
~24 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top